Article

Ordering correct imaging studies key to diagnosing primary optic nerve tumors

Magnetic resonance imaging (MRI) is the procedure of choice for evaluating patients with possible primary optic nerve tumors.

Chicago-Magnetic resonance imaging (MRI) is the procedure of choice for evaluating patients with possible primary optic nerve tumors. Computerized axial tomography (CT), however, may also useful for showing calcification in meningioma, explained Andrew G. Lee, MD, professor of ophthalmology, neurology, and neurosurgery, University of Iowa Hospitals and Clinics.

The two primary optic nerve tumors are optic nerve glioma, usually found in children, and optic nerve sheath meningioma, seen in middle-aged women, said Dr. Lee, during a session on therapeutic neuro-ophthalmology at the subspecialty day meeting in Chicago.

Clinical findings for primary optic nerve tumors include ipsilateral loss of visual acuity and/or visual field, dyschromatopsia, relative afferent pupillary defect, proptosis, optic disc edema, or atrophy.

“We don’t usually have to perform a biopsy of these lesions. The imaging alone is normally characteristic enough to make the diagnosis of glioma or meningioma,” Dr. Lee said.

“The head and orbit are required in your imaging study. Be sure to order a fat suppression and gadolinium contrast,” he said. “CT scan still might have a role for calcification in meningioma.”

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.